Quantification of abciximab-induced platelet inhibition is assay dependent: a comparative study in patients undergoing percutaneous coronary intervention

MLA

Lori A. Krueger, et al. “Quantification of Abciximab-Induced Platelet Inhibition Is Assay Dependent: A Comparative Study in Patients Undergoing Percutaneous Coronary Intervention.” American Heart Journal, vol. 145, no. 2, Feb. 2003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b78b549b902e2cdfe0aa149f584a0ddb&authtype=sso&custid=ns315887.

APA

Lori A. Krueger, Mark I. Furman, Dean J. Kereiakes, Thomas M. Broderick, Andrew L. Frelinger, Marsha L. Fox, Wendy L. Howard, Michele N. Mueller, Marc R. Barnard, John F. Schneider, & Alan D. Michelson. (2003). Quantification of abciximab-induced platelet inhibition is assay dependent: a comparative study in patients undergoing percutaneous coronary intervention. American Heart Journal, 145(2).

Chicago

Lori A. Krueger, Mark I. Furman, Dean J. Kereiakes, Thomas M. Broderick, Andrew L. Frelinger, Marsha L. Fox, Wendy L. Howard, et al. 2003. “Quantification of Abciximab-Induced Platelet Inhibition Is Assay Dependent: A Comparative Study in Patients Undergoing Percutaneous Coronary Intervention.” American Heart Journal 145 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b78b549b902e2cdfe0aa149f584a0ddb&authtype=sso&custid=ns315887.